In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI),
gadopentetate dimeglumine (Magnevist®), became available for clinical use. Since then, a …

Dynamic breast MRI provides information on both lesion cross‐sectional morphology and
functional lesion features such as vascularity/perfusion and vessel permeability. This review …

Background Chylothorax arises when lymphatic fluid (chyle) accumulates in the pleural
cavity because of leakage from lymphatic vessels. It is most commonly seen after thoracic …

PURPOSE: To assess the relevance of the signal intensity time course for the differential
diagnosis of enhancing lesions in dynamic magnetic resonance (MR) imaging of the breast …

Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of
Women at High Familial Risk for Breast Cancer Page 1 Mammography, Breast Ultrasound …

Background Diagnosing breast cancer in its intraductal stage might be helpful to prevent the
development of invasive cancer. Our aim was to investigate the sensitivity with which ductal …

Purpose We investigated whether an abbreviated protocol (AP), consisting of only one pre-
and one postcontrast acquisition and their derived images (first postcontrast subtracted …

PURPOSE: To define the range of normal contrast medium enhancement, the variability in
contrast medium enhancement patterns in healthy premenopausal breast parenchyma, and …

PURPOSE: To compare magnetic resonance (MR) imaging with conventional imaging in
screening high-risk women. MATERIALS AND METHODS: This prospective trial included …

Purpose We investigated the respective contribution (in terms of cancer yield and stage at
diagnosis) of clinical breast examination (CBE), mammography, ultrasound, and quality …